Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;36(9):2665-2667.
doi: 10.1007/s40620-023-01754-1. Epub 2023 Sep 13.

Prevalence of SARS-CoV-2 infection and impact of vaccination in dialysis patients over two years of the pandemic

Paolo Hitz  1 , Alberto Pagnamenta  2   3   4 , Laura Pertusini  5 , Tatiana Terrot  2 , Yves Franzosi  2 , Jessica Bassi  6 , Chiara Silacci-Fregni  6 , Valeria Gaia  7 , Gladys Martinetti  7 , Franco Keller  7 , Lorenzo Berwert  5   8 , Valentina Forni Ogna  1   5 , Soraya Lavorato-Hadjeres  5 , Davide Giunzioni  5 , Andrea D'Ermo  9 , Alan Valnegri  9 , Paolo Ferrari  1   8   10 , Davide Corti  6 , Alessandro Ceschi  1   2   11   12 , Pietro Cippà  1   5   8 , Luca Piccoli  6 , Olivier Giannini  13   14   15
Affiliations

Prevalence of SARS-CoV-2 infection and impact of vaccination in dialysis patients over two years of the pandemic

Paolo Hitz et al. J Nephrol. 2023 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

J.B., C.S.-F., D.C. and L.Pi. are employees of Vir Biotechnology Inc. and may hold shares in Vir Biotechnology Inc. The other authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
Overview of prevalence and outcomes during the COVID-19 pandemic in dialysis patients. Shown are number (n) and percentage (%) of patients and positive cases on maintenance dialysis throughout the pandemic (first 26 months), the individual waves identified on COVID-19-related hospitalizations in the EOC hospital and the pre- and post-vaccination periods. NA not applicable evaluation of mortality in the retrospective phase of the study (first wave)
See this image and copyright information in PMC

References

    1. Barouch DH. Covid-19 vaccines–immunity, variants. Boosters N Engl J Med. 2022;387:1011–1020. doi: 10.1056/NEJMra2206573. - DOI - PMC - PubMed
    1. Aylward R, Bieber B, Guedes M, et al. The global impact of the covid-19 pandemic on in-center hemodialysis services: an isn-dialysis outcomes practice patterns study survey. Kidney Int Rep. 2022;7:397–409. doi: 10.1016/j.ekir.2021.12.011. - DOI - PMC - PubMed
    1. Beretta O, Casati Pagani S, Lazzaro M, Merlani G, Bouvier GM. Seroprevalence of the SARS-CoV-2 virus in the population of the southern Switzerland (Canton Ticino)—cohort study, results at 12 months. Swiss Med Wkly. 2021;151:w30116. doi: 10.4414/SMW.2021.w30116. - DOI - PubMed
    1. Rodriguez-Espinosa D, Montagud-Marrahi E, Cacho J, et al. Incidence of severe breakthrough SARS-CoV-2 infections in vaccinated kidney transplant and haemodialysis patients. J Nephrol. 2022;35:769–778. doi: 10.1007/s40620-022-01257-5. - DOI - PMC - PubMed
    1. Ashby DR, Caplin B, Corbett RW, et al. Severity of COVID-19 after vaccination among hemodialysis patients: an observational cohort study. Clin J Am Soc Nephrol. 2022;17:843–850. doi: 10.2215/CJN.16621221. - DOI - PMC - PubMed

Publication types